• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用间歇性高剂量细胞抑制剂的癌症治疗]

[Cancer therapy using intermittent high doses of cytostatics].

作者信息

Hartenstein R

出版信息

Fortschr Med. 1976 May 6;94(13):765-70.

PMID:955537
Abstract

The results of intermittent high-dose-therapy, especially with Doxorubicin and Amethopterin, are encouraging, particularly, against those malignant tumors which were difficult to influence until now. The damage to normal tissue and especially the therapy-limiting cumulative toxicity, seem to be lower if compared with the continuous low-dose-treatment because of the possibility for complete recovery of normal tissue during therapy-free intervals. Correlations between tumor, normal tissue and cytotoxic agent are discussed on the basis of cellkinetic findings to contribute to a better understanding of the way of action of a high-dose-therapy.

摘要

间歇性高剂量疗法的结果,尤其是使用阿霉素和氨甲蝶呤的疗法,令人鼓舞,特别是对于那些迄今为止难以治疗的恶性肿瘤。与持续低剂量治疗相比,对正常组织的损害,尤其是限制治疗的累积毒性,似乎更低,因为在无治疗间隔期正常组织有可能完全恢复。基于细胞动力学研究结果讨论了肿瘤、正常组织和细胞毒性药物之间的相关性,以有助于更好地理解高剂量疗法的作用方式。

相似文献

1
[Cancer therapy using intermittent high doses of cytostatics].[使用间歇性高剂量细胞抑制剂的癌症治疗]
Fortschr Med. 1976 May 6;94(13):765-70.
2
Evolving concepts in the systemic drug therapy of breast cancer.乳腺癌全身药物治疗的概念演变
Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-3-S10-10.
3
A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.实体瘤自体骨髓移植剂量密集疗法的观点
Oncology (Williston Park). 1991 Mar;5(3):25-33; discussion 33, 36, 41.
4
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗:含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
5
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.多种化疗药物用于节拍化疗的抗血管生成效力
Anticancer Res. 2004 May-Jun;24(3a):1759-63.
6
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.通过将天然脂肪酸与紫杉醇共价偶联实现肿瘤靶向
Clin Cancer Res. 2001 Oct;7(10):3229-38.
7
Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.使用131I-MN-14 F(ab)2抗癌胚抗原单克隆抗体和AHSCR对转移性甲状腺髓样癌进行高剂量放射免疫治疗的初步经验。
J Nucl Med. 2000 Jan;41(1):93-103.
8
Current concepts for chronochemotherapy of cancer.癌症时辰化疗的当前概念。
J Infus Chemother. 1995;5(3 Suppl 1):159-70.
9
Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.阿普利丁可降低间变性甲状腺癌异种移植瘤的生长以及几种血管生成基因的表达。
Cancer Chemother Pharmacol. 2006 Jan;57(1):7-14. doi: 10.1007/s00280-005-0014-7. Epub 2005 Nov 5.
10
[High-dose chemotherapy--a new hope for some patients with malignant tumors?].[大剂量化疗——某些恶性肿瘤患者的新希望?]
Vnitr Lek. 1997 Dec;43(12):809-14.